/compare — side-by-sideLOADING

compare stocks // side-by-side, from filings

Compare any stocks, on the real numbers

Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.

Metric	GOVXGeoVax Labs, Inc.
Last close	$0.16close 2026-11-02
Change %	-3.32%close 2026-11-02
Market cap	$1Mclose 2026-11-02
P/E	loss, no P/E
Revenue	$2M ⊙ EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerIncludingAssessedTax As ofFY ending 2025-12-31 FilingS-1 · 0001437749-26-030676 · filed 2026-09-17 Open the filing on EDGAR →Open the XBRL payload → CiteGeoVax Labs, Inc. (GOVX), us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax: 2,489,145 USD, fiscal year ended 2025-12-31. Form S-1, accession 0001437749-26-030676, filed 2026-09-17. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000832489/us-gaap/RevenueFromContractWithCustomerIncludingAssessedTax.json

Share this comparisonSend GOVX side-by-side — free, straight from the filings.

Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.